Evaluation of a new oral compound, Abbott-16612 in the treatment of bilharziasis.
D006801:Humans; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011208:Powders; D012552:Schistosomiasis / Q000188:drug therapy*
D010879:Piperazines; D011208:Powders